ArticleEuropean journal of clinical nutrition2026
A single centre experience of refeeding hypophosphataemia and refeeding syndrome in parenteral nutrition and a proposal for a sub-fulminant categorisation.
Article in European journal of clinical nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundRefeeding syndrome (RFS) is an uncommon, but potentially serious, complication of nutrition therapy. There remains a lack of consensus as to the clinical definition of RFS and refeeding hypophosphataemia (RH), and what measures should be included to assess risk. This study aims to evaluate the prevalence of RH and RFS using previously proposed criteria in our cohort of patients receiving parenteral nutrition (PN), and assess the National Institute for Health and Care Excellence guidelines as risk factors.
methodsA single-centre prospective cohort study of adult patients (age ≥18 years) receiving PN for more than 48 h over a 5 year period. Prevalence of RH was determined using four previously established diagnostic criteria and RFS by the King's College criteria. Risk factors were assessed using univariate analysis and multiple logistic regression.
results354 cases fulfilled the inclusion criteria. 4.5-13.3% (17-47 of the 354 cases) met at least one of the criteria for RH. No cases met the criteria for RFS. Thirteen (3.7%) cases with RH manifested signs of fluid overload without an alternative explanation except possible refeeding syndrome. Weight loss above 10% over 3-6 months (P = 0.03), serum albumin (P = 0.02), and serum haemoglobin (P = 0.01) were factors associated with RH.
conclusionPrevalence of RH varies considerably according to the established criteria used, but overall remains uncommon. Previously defined RFS was not seen in our cohort of patients. A combination of RH and fluid overload without an alternative cause may represent sub-fulminant RFS.
Identifiers
42778586What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.